L
Lev Levanov
Researcher at University of Helsinki
Publications - 32
Citations - 3063
Lev Levanov is an academic researcher from University of Helsinki. The author has contributed to research in topics: Virus & Antibody. The author has an hindex of 13, co-authored 26 publications receiving 2058 citations.
Papers
More filters
Journal ArticleDOI
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
Ludovico Cantuti-Castelvetri,Ludovico Cantuti-Castelvetri,Ravi Ojha,Liliana D. Pedro,Liliana D. Pedro,Minou Djannatian,Minou Djannatian,Jonas Franz,Suvi Kuivanen,Franziska van der Meer,Katri Kallio,Tuğberk Kaya,Tuğberk Kaya,Tuğberk Kaya,Maria Anastasina,Maria Anastasina,Teemu Smura,Lev Levanov,Leonora Szirovicza,Allan Tobi,Hannimari Kallio-Kokko,Pamela Österlund,Merja Joensuu,Frederic A. Meunier,Sarah J. Butcher,Sarah J. Butcher,Martin Sebastian Winkler,Brit Mollenhauer,Ari Helenius,Ozgun Gokce,Tambet Teesalu,Tambet Teesalu,Tambet Teesalu,Jussi Hepojoki,Jussi Hepojoki,Olli Vapalahti,Christine Stadelmann,Giuseppe Balistreri,Giuseppe Balistreri,Mikael Simons,Mikael Simons +40 more
TL;DR: It is found that neuropilin-1 (NRP1), known to bind furin-cleaved substrates, significantly potentiates SARS-CoV-2 infectivity, an effect blocked by a monoclonal blocking antibody against NRP1.
Journal ArticleDOI
Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities.
Rita W. Driggers,Cheng-Ying Ho,Essi M. Korhonen,Suvi Kuivanen,Anne J. Jääskeläinen,Teemu Smura,Avi Z. Rosenberg,D. Ashley Hill,Roberta L. DeBiasi,Gilbert Vezina,Julia Timofeev,Fausto J. Rodriguez,Lev Levanov,Jennifer Razak,Preetha Iyengar,Andrew K. Hennenfent,Richard Kennedy,Robert S. Lanciotti,Adre J. du Plessis,Olli Vapalahti +19 more
TL;DR: A case of a pregnant woman and her fetus infected with ZIKV during the 11th gestational week and postmortem analysis of the fetal brain finds substantial brain abnormalities without the presence of microcephaly or intracranial calcifications is described.
Journal ArticleDOI
Zika Virus Infection With Prolonged Maternal Viremia and Fetal Brain Abnormalities
Rita W. Driggers,Cheng-Ying Ho,Essi M. Korhonen,Suvi Kuivanen,Annemarjut J. Jääskeläinen,Teemu Smura,Avi Z. Rosenberg,D.A. Hill,Roberta L. DeBiasi,G. Vezina,Julia Timofeev,Fausto J. Rodriguez,Lev Levanov,Jennifer Razak,Preetha Iyengar,Andrew K. Hennenfent,R. Kennedy,Robert S. Lanciotti,A. du Plessis,Olli Vapalahti +19 more
TL;DR: Findings provide additional evidence for the association between congenital ZIKV infection and fetal brain damage and future studies focusing on infection at various gestational ages may provide better insight into the role of ZikV infection in abnormal brain development and further tools for detection.
Journal ArticleDOI
Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19.
Lucie Rodriguez,Pirkka T. Pekkarinen,Tadepally Lakshmikanth,Ziyang Tan,Camilla Rosat Consiglio,Christian Pou,Yang Chen,Constantin Habimana Mugabo,Ngoc Anh Nguyen,Kirsten Nowlan,Tomas Strandin,Lev Levanov,Jaromír Mikeš,Ju Wang,Anu Kantele,Jussi Hepojoki,Olli Vapalahti,Santtu Heinonen,Eliisa Kekäläinen,Petter Brodin,Petter Brodin +20 more
TL;DR: An IFNγ – Eosinophil axis activated prior to lung hyperinflammation and changes in cell-cell coregulation during different stages of the disease are described and map an immune trajectory during recovery that is shared among patients with severe COVID-19.
Posted ContentDOI
Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system
Ludovico Cantuti-Castelvetri,Ravi Ohja,Liliana D. Pedro,Minou Djannatian,Jonas Franz,Suvi Kuivanen,Katri Kallio,Tugberg Kaya,Maria Anastasina,Teemu Smura,Lev Levanov,Leonora Szirovicza,Allan Tobi,Hannimari Kallio-Kokko,Pamela Osterlund,Merja Joensuu,Frederic A. Meunier,Sarah J. Butcher,Martin Sebastian Winkler,Brit Mollenhauer,Ari Helenius,Ozgun Gokce,Tambet Teesalu,Jussi Hepojoki,Olli Vapalahti,Christine Stadelmann,Giuseppe Balistreri,Mikael Simons +27 more
TL;DR: It is found that the cellular receptor neuropilin-1 (NRP1), known to bind furin-cleaved substrates, significantly potentiates SARS-CoV-2 infectivity, which was inhibited by a monoclonal blocking antibody against the extracellular b1b2 domain of NRP1.